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Nutrient and Metabolic Sensing in  
T Cell Responses
Jun Wei, Jana Raynor, Thanh-Long M. Nguyen and Hongbo Chi*
Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, USA
T cells play pivotal roles in shaping host immune responses in infectious diseases, auto-
immunity, and cancer. The activation of T cells requires immune and growth factor-derived 
signals. However, alterations in nutrients and metabolic signals tune T cell responses by 
impinging upon T cell fates and immune functions. In this review, we summarize how key 
nutrients, including glucose, amino acids, and lipids, and their sensors and transporters 
shape T cell responses. We also briefly discuss regulation of T cell responses by oxygen 
and energy sensing mechanisms.
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iNTRODUCTiON
T cells express specific T cell receptors (TCRs) and play pivotal roles in cell-mediated immunity 
during infection, autoimmune diseases, and cancer. Conventional αβ T cells are divided into two 
major lineages based on the exclusive expression of the co-receptor CD8 or CD4 (1). Upon cognate 
antigen stimulation, naïve CD8+ T cells expand and differentiate into cytotoxic effector cells to clear 
infected or malignant cells. After this rapid expansion, effector CD8+ T cells undergo contraction, 
and only a small subset of them eventually forms the memory population (2). Likewise, naïve CD4+ 
T cells are activated by cognate antigens and undergo proliferation and functional specialization. In 
response to an instructive cytokine milieu, naïve CD4+ T cells differentiate into functionally distinct 
T helper cells, including TH1, TH2, TH17, and TFH effector cells, and immunosuppressive Treg cells (3). 
Although immune receptors, signaling proteins and transcriptional factors allow T cells to sense and 
transduce antigenic and inflammatory signals, emerging studies highlight that cellular metabolism 
is dynamically regulated to control T cell survival, proliferation, and function (4). Nutrients are the 
basis of cellular metabolism, with glucose, amino acids, and lipids playing crucial roles in immune 
signaling and immune cell functions (5). Because T cell priming and function occur within discrete 
microenvironments, they must adapt to changes in nutrient and environmental signals to mount 
effective adaptive immune responses.
Nutrient-sensing systems, composed of sensors, transporters, and signaling proteins, are utilized 
by cells to monitor and respond to fluctuations in environmental nutrient levels. Several evolutionar-
ily conserved nutrient-sensing systems have been identified (6, 7). Recently, extensive efforts have 
been made to dissect mechanisms of nutrient sensing in T cells. This review article first discusses 
the regulation and function of glucose metabolism in T cell responses. Second, we summarize recent 
findings on how specific amino acids and amino acid transporters control T cell responses. Third, we 
summarize the contributions of fatty acid (FA) and cholesterol sensing to T cell-mediated immunity. 
Finally, we briefly discuss how T cells adapt to oxygen levels and energy stress to maintain their 
functions.
FigURe 1 | glucose sensing shapes T cell immune responses. Glucose transporter 1 (Glut1) transports glucose into T cells to fuel glycolysis. The generation 
of effector T cells, including TH1, TH2, TH17, and TFH cells, is dependent on Glut1 expression and glycolytic metabolism. While Glut1 expression and glycolysis 
promote Treg cell proliferation, they impair Treg cell lineage stability and suppressive function. Thus, Glut1 expression provides a key mechanism to shape T cell 
responses. Glycolysis also promotes the formation of effector memory CD8+ T cells (TEM). TCR and CD28 co-stimulation potently induces Glut1 expression, while the 
translocation of Glut1 from the cytoplasm to T cell surface is induced by various stimuli, including TCR-CD28, IL-7, and insulin.
2
Wei et al. Nutrient Sensing in T Cells
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 247
gLUCOSe SeNSiNg
Glucose is a major cellular nutrient that serves as a critical fuel for 
cellular adenosine triphosphate (ATP) generation and precursor 
for biosynthetic pathways. T cell activation, subset differentiation, 
and effector function are tightly regulated by glucose metabolism 
as detailed below (Figure 1).
glucose Metabolism in Conventional  
T Cell Activation, Differentiation, and 
Memory Formation
Activated T cells use glucose metabolism to fulfill the metabolic 
requirements for rapid proliferation and biosynthesis supporting 
cellular growth and differentiation (4). Such demands are met, 
in part, by upregulation of glucose transporter 1 (Glut1) during 
T cell activation. Naïve T cells express low levels of Glut1 on the 
cell surface, but Glut1 expression and surface localization are sig-
nificantly increased in activated T cells (8–10). Several upstream 
signals regulate Glut1 expression in T  cells. TCR and CD28 
co-stimulation induces the expression and surface localization of 
Glut1 in T cells (10). The phosphoinositol-3 kinase (PI(3)K)-Akt 
pathway triggers the translocation of Glut1 from cytoplasm to 
T cell surface (9, 10). Other stimuli also increase surface Glut1 
levels on T  cells; for example, IL-7-induced STAT5 signaling 
and downstream Akt activation induce Glut1 trafficking to the 
cell surface in both naïve and activated T  cells (11). Increased 
surface expression of Glut1 is observed on memory CD4+ T cells 
upon insulin stimulation through a mechanism that requires 
Notch-Akt signaling (12). In human CD4+ T cells, the SLC2a1 
(encodes for human Glut1) mRNA transcript is targeted by 
miR-150, whose expression is downregulated by co-stimulation 
with the complement receptor CD46 (13). CD46 signaling is also 
important for effective TH1 cell differentiation by potentiating 
TCR-driven Glut1 expression and surface translocation (14).
Extensive efforts have been made to determine the role of 
Glut1 in T cell responses. While Glut1 overexpression does not 
alter T cell development, it enhances activated T cell prolifera-
tion and growth (10, 15), and generation of TFH cells (16). Also, 
TH1, TH2, and TH17 cells express high levels of Glut1 and are 
highly glycolytic (15, 17). Consistent with this observation, 
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conditional deletion of Slc2a1 (encodes for mouse Glut1) in 
the T  cell compartment leads to defective generation of TH1, 
TH2, and TH17 cells both in  vitro and in  vivo (8). How Glut1 
expression and glucose metabolism specifically contribute to 
the functional specialization of effector CD4+ T  cell subsets 
requires further investigation. Transgenic expression of Glut1 
leads to an accumulation of activated/memory phenotype T cells 
in vivo, suggesting a role of glucose metabolism in T cell memory 
responses (10, 15). Memory T cells have reduced glycolysis as 
compared to effector T cells (18), but Glut1 expression and glu-
cose uptake are essential for CD4+ memory T cell maintenance 
(12). A recent study demonstrates that constitutive glycolysis 
promotes the formation of effector memory CD8+ T cells (TEM) 
in a murine genetic model with T cell-specific deletion of a key 
hypoxia-inducible factor 1α (HIF1α) negative regulator, Von 
Hippel-Lindau (VHL) (19). Consistent with these observations, 
Glut1 expression favors human TEM formation (20). Moreover, 
the rapid acquisition of effector functions by human TEM requires 
immediate-early glycolysis upon activation (21). Thus, Glut1 and 
glucose metabolism are essential for effector and TEM responses. 
Further studies are required to reveal the underlying molecular 
mechanisms.
Recent studies have uncovered important roles of glucose 
competition between tumor cells and effector T cells within the 
tumor microenvironment (22–24). Similar to T cells, tumor cells 
rewire their metabolism to greatly increase glucose uptake and 
aerobic glycolysis, which is known as the Warburg Effect (25). The 
functional state of tumor-infiltrating T cells is positively corre-
lated with their glycolytic activity and glucose availability within 
tumor tissues (23, 24). Due to the limited glucose levels in the 
tumor microenvironment, tumor-infiltrating T cells produce less 
IFN-γ than T cells taken from glucose-replete environments (23). 
Mechanistically, this is linked to the ability of glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) to serve as both a glyco-
lytic enzyme and RNA-binding protein (26, 27). When aerobic 
glycolysis is inhibited, GAPDH binds to the Ifng (encodes for 
IFN-γ) mRNA transcript to suppress its translation (28). Aerobic 
glycolysis also plays a pivotal role in sustaining TCR-mediated 
calcium-NFAT signaling to maintain T  cell effector functions 
(24). Specifically, phosphoenolpyruvate (PEP) generated during 
glycolysis maintains cytosolic calcium levels by suppressing sacro/
endoplasmic reticulum calcium ATPase activity (24). Notably, 
increasing PEP production enhances anti-tumor T cell responses 
(24). Removing the metabolic restrictions in T  cells may also 
contribute to the therapeutic effects of checkpoint blockade 
therapies, including anti-CTLA4, anti-PD-1, and anti-PD-L1 
antibody administrations, since those treatments restore glucose 
levels within tumors and glycolytic metabolism in T cells (23). 
More research is needed to determine the therapeutic potential 
of targeting the components of glucose sensing and metabolism 
in T cells in cancer patients.
glucose Metabolism in Treg Cells
The roles of glycolytic metabolism have also been investigated in 
suppressive Foxp3+ Treg cells. Murine Treg cells express comparable 
levels of Glut1 as naïve T cells but lower levels of Glut1 than effec-
tor T cells (8, 15). Such regulation of Glut1 expression is partially 
dependent on elevated AMP-activated protein kinase (AMPK) 
activation in Treg cells (15). Foxp3, the master transcription factor 
that governs Treg cell differentiation and function, limits Glut1 
expression through inhibiting Akt (29). Glut1 deficiency does not 
affect Treg cell suppressive function but increases the proportion 
of Treg cells in the peripheral CD4+ T cell compartment (8). In 
contrast, Treg cells with aberrant increases in glucose metabolism 
tend to lose their lineage stability. Indeed, murine Treg cells with 
elevated Glut1 expression have reduced CD25 and Helios expres-
sion and are unable to maintain Foxp3 expression and suppressive 
function in a murine inflammatory bowel disease model, indica-
tive of reduced Treg cell stability (30). These results are consistent 
with recent findings that aberrant glycolysis is detrimental to Treg 
cell lineage stability and functional integrity (31–33). Of note, 
proliferating human and murine Treg cells have elevated glucose 
uptake and glycolysis than non-dividing Treg cells, and glycolysis 
contributes to the functional differentiation of human Treg cells 
by inducing FOXP3 expression (34, 35). These studies highlight a 
pivotal role of glucose metabolism in balancing the proliferation 
and suppressive function of Treg cells, which is likely important 
for controlling effector and suppressive T cell responses during 
infection and inflammation.
AMiNO ACiD SeNSiNg
Amino acids are the building blocks for protein synthesis, and 
their uptake into cells is critical for cellular function. During 
cellular division, the influx of amino acids is especially critical to 
meet the increased demands for protein synthesis. Furthermore, 
amino acids can serve as sources for metabolites that enter 
into metabolic processes, such as the tricarboxylic acid (TCA) 
cycle. Such energy-demanding cellular processes must be tightly 
regulated, requiring the sensing of extracellular and intracellular 
amino acid abundance. Recent studies have begun to identify 
specific amino acids and amino acid transporters that are critical 
in regulating T cell homeostasis and function (Figure 2).
Leucine and glutamine
Amino acids are critical for efficient T cell activation and prolif-
erative responses (36). The SLC7 amino acid transporter family 
contributes to the uptake of amino acids by T  cells. The SLC7 
amino acid transporter family is comprised of the cationic amino 
acid transporters (SLC7A1-4, CAT1-4, and SLC7A14) and the 
glycoprotein-associated amino acid transporters (SLC7A5-13, 
SLC7A15) (37). Antigen signaling through the TCR increases 
phenylalanine, leucine, and glutamine uptake into CD8+ T cells 
(38, 39). Furthermore, the expression of many SLC7 transport-
ers, including Slc7a5 (encodes for LAT1), is upregulated during 
activation in both mouse and human T cells (38, 40), which may 
be mediated by TCR-induced ERK/MAPK signaling (39). LAT1 
associates with CD98 (encoded by Slc3a2) to form a high-affinity 
transporter that facilitates the bidirectional influx of leucine and 
efflux of glutamine from cells (38, 41). LAT1 is not required for 
normal T cell development; however, LAT1-deficient CD8+ T cells 
have impaired primary effector expansion following antigenic 
stimulation (38). Mechanistically, leucine uptake induces activa-
tion of mechanistic target of rapamycin complex 1 (mTORC1) 
FigURe 2 | Amino acid sensing modulates T cell responses. Antigen-driven activation of T cells through TCRs upregulates expression of many amino acid 
transporters, including the leucine and glutamine transporters LAT1, ASCT2, and CD98. LAT1 associates with CD98, forming a bidirectional transporter for leucine 
and glutamine. The intracellular sensors of leucine and glutamine in T cells remain unknown. mTORC1 is activated downstream of intracellular amino acids, leading 
to the regulation of CD4+ T cell differentiation (TH1 and TH17) and CD8+ T cell effector responses. Elevated intracellular l-arginine levels promote effector CD8+ T cell 
anti-tumor immunity and effector CD4+ T cell IFN-γ production and survival. Although the intracellular mediators critical for arginine sensing are unclear, three 
potential sensors are BAZ1B, PSIP1, and TSN.
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in effector CD8+ T  cells and promotes c-Myc expression (38). 
Furthermore, the loss in c-Myc expression in CD8+ T cells cor-
relates with impaired glucose, glutamine, and arginine uptake 
and impaired glycolytic metabolism, which promote proper 
CD8+ T cell effector function (38, 42). Thus, leucine is a positive 
regulator of peripheral CD8+ T cell functionality. There is much 
left to be understood how amino acid sensing regulates CD8+ 
T cell responses. For instance, while glutamine receptor ASCT2 
(encoded by Slc1a5) is dispensable for CD8+ T cell development 
(41), how ASCT2 regulates CD8+ T  cell effector and memory 
responses has not been explored.
Both leucine and glutamine are positive regulators of CD4+ 
T cell differentiation into TH1 and TH17 cells. Indeed, the absence 
of LAT1 expression impairs TH1 and TH17 cell differentiation 
in vitro (38), and elevated glutamine levels favor TH1 and TH17 
cell differentiation in vitro (41). Consistent with these observa-
tions, ASCT2 is important for TH1 and TH17 cell differentiation 
(41). Likely due to the bidirectional transport of glutamine and 
leucine via LAT1, activated ASCT2-deficient CD4+ T cells also 
have decreased leucine uptake (41, 43). Interestingly, highly 
elevated leucine levels favor TH17 differentiation, but impair 
TH1 differentiation in vitro, indicating that high concentrations 
of leucine may negatively regulate TH1 differentiation (41). 
Glutaminolysis plays crucial roles in replenishing the TCA 
cycle under conditions of aerobic glycolysis and supports T cell 
activation (42). Furthermore, the glutamine-derived metabolite 
alpha-ketoglutarate promotes TH1 differentiation, potentially 
through enhancing mTORC1 signaling (44). Unlike TH1 and 
TH17 cells, TH2 and Treg cells do not require the expression of 
LAT1 or ASCT2 for their differentiation in vitro (38, 41), likely 
due to their altered dependency on mTOR signaling (45). Indeed, 
Treg cell differentiation is favored during glutamine deprivation 
(44). Thus, leucine and glutamine likely act in concert to regulate 
the threshold of mTORC1 signaling and subsequent CD4+ T cell 
differentiation.
Arginine
Arginine is transported into cells through the cationic trans-
porters CAT1-4 (46), where it is metabolized by arginase 1 or 
nitric-oxide synthase 2 (46). Myeloid-derived suppressor cells, 
which are elevated in tumor microenvironment and other 
disease states, consume and deplete extracellular arginine (46). 
These arginine-depleted environments impair T cell proliferation 
(47–50). Arginine is also directly metabolized in T  cells (51). 
Activated T cells have increased l-arginine metabolism mediated 
by arginase 2, which contributes to enhanced CD4+ and CD8+ 
T cell survival and anti-tumor immunity (51). Interestingly, Arg2-
deficient CD4+ and CD8+ T cells have elevated levels of intracel-
lular l-arginine, which correlates with increased survival after 
IL-2 withdrawal (51), suggesting that additional arginine-sensing 
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pathways contribute to T cell survival. While the mechanisms of 
how arginine is sensed within T  cells remain elusive, BAZ1B, 
PSIP1, and Translin are potential arginine sensors that promote 
T  cell survival (51). Interestingly, these survival effects appear 
to be independent of modulating mTORC1 activation, which 
is a known downstream sensor of arginine in other cell lineages 
(52–54). Thus, regulation of arginine availability and sensing is 
critical for T  cell functionality and combating environmental 
insults, such as infections and tumors. Future studies can explore 
how lysine and ornithine, whose uptake is also CAT dependent, 
contribute to T cell responses.
Serine
Serine is a non-essential amino acid that is synthesized intracel-
lularly from the glycolytic intermediate 3-phosphoglycerate, 
or directly transported into cells (55). Recent work reveals 
that serine metabolism is enhanced in activated T  cells and 
provides intracellular glycine and one-carbon units for purine 
nucleotide biosynthesis, thereby supporting T cell proliferation 
(56). Serine uptake is critical for effector T  cell responses, as 
serine and glycine-limiting conditions impair anti-CD3/CD28 
antibody-driven CD4+ and CD8+ T  cell proliferation in  vitro 
(56). Furthermore, mice on a serine and glycine-restricted diet 
have impaired antigen-driven CD8+ effector T cell expansion and 
pathogen clearance (56). These findings elucidate a novel role for 
serine metabolism in effector T cell responses.
Tryptophan
Indoleamine 2,3-dioxygenase (IDO) catabolizes the amino 
acid tryptophan, resulting in localized tryptophan depletion. 
Tryptophan depletion is then sensed by general control non-
derepressible 2 (GCN2), which has a high affinity for uncharged 
tRNAs that accumulate when intracellular amino acid abundance 
is low. GCN2 binding to uncharged tRNAs induces GCN2 kinase 
activity, which subsequently inhibits protein translation via the 
phosphorylation of eIF2α (6). It has been demonstrated that 
GCN2 sensing of amino acid deprivation in activated T  cells 
promotes T cell survival, limits T cell proliferation, and induces 
T cell anergy (36, 57). In contrast to these findings, a recent study 
has shown that both control and GCN2-deficient CD4+ and CD8+ 
T  cells have impaired proliferation when tryptophan, arginine, 
lysine, leucine, or asparagine levels are low, suggesting additional 
pathways contribute to sensing amino acid deprivation in T cells 
(58). IDO may also influence T cell responses independently of 
GCN2 kinase activity by altering the inflammatory environment. 
Indeed, tryptophan metabolites promote Treg cell differentiation 
indirectly by increasing TGF-β production by dendritic cells 
(DCs) (59). Furthermore, blocking IDO promotes IL-6 produc-
tion by plasmacytoid DCs, which enables skewing of CD4+ 
T  cells toward the TH17 cell subset and suppression of Treg cell 
development (60, 61). Consequently, IDO deficiency promotes 
TH17 differentiation and exacerbates experimental autoimmune 
encephalomyelitis (EAE), a murine model of human multiple 
sclerosis (59). Thus, the IDO-tryptophan degradation pathway 
plays a regulatory role in local inflammation driving TH17 cell 
responses.
LiPiD SeNSiNg
Lipid molecules, including FAs and sterols, are essential for 
cellular function, serving important functions in membrane 
biosynthesis and intracellular signaling. Several studies indicate 
roles for cholesterol and FAs in activation, differentiation, and 
function of T cells as discussed below (Figure 3).
Fatty Acids
The basic structure of a FA is a carboxylic acid linked to a satu-
rated or unsaturated aliphatic chain. FAs are categorized broadly 
into groups based on the length of the aliphatic chain. Short-chain 
fatty acids (SCFAs) have 2–6 carbons; medium chain fatty acids 
have 7–12 carbons; and long chain fatty acids (LCFAs) have more 
than 12 carbons (62). Some FAs are generated within the cell 
through de novo synthesis; however, many important FAs cannot 
be synthesized and are obtained only through dietary sources. For 
instance, when dietary fats and fibers are catabolized in the liver 
and intestines, respectively, free fatty acids (FFAs) are generated 
and circulate through the blood (62). Although certain FFAs can 
diffuse across the plasma membrane into the cytosol, most require 
transport facilitated by surface receptors. LCFAs and oxidized FAs 
are transported across the membrane by fatty acid translocase 
(FAT or CD36) (63). Additionally, several G protein receptors 
bind FAs of various lengths—GPCR40 (free fatty acid receptor 
1) and GPCR120 bind to LCFAs; GPCR84 recognizes MCFAs; 
GPCR43 (FFA2) and GPCR41 (FFA3) bind to SFCAs (62).
Several studies have revealed roles for SFCAs and their trans-
porters in T cell responses. The breakdown of dietary fibers into 
acetate, butyrate, and propionate by intestinal bacteria plays an 
important role in controlling T cell inflammatory responses. For 
instance, within the intestines, these SCFAs bind the GPCR43 
receptor on Treg cells and promote their differentiation and func-
tion to maintain intestinal homeostasis (64, 65). Mechanistically, 
butyrate inhibits histone deacetylase (HDAC) activity, subse-
quently enhancing histone acetylation in the Foxp3 promoter 
to promote stable Foxp3 expression (64, 66, 67). Interestingly, 
these intestine-derived SCFAs also promote the generation of 
Treg cells in distal tissues (66) and shape inflammatory responses 
within the central nervous system, kidneys, and lungs (68–71). 
For example, during an acute Listeria monocytogenes infection, 
serum levels of acetate increase, which is required for optimal 
memory CD8+ T cell formation (72). The increase in intracellular 
acetate enhances glycolytic activity necessary for a rapid recall 
response by CD8+ T cells (72). Mechanistically, the accumulation 
of acetate drives GAPDH acetylation to increase glycolytic flux 
(72). Furthermore, SCFA-mediated inhibition of HDAC activ-
ity increases the acetylation of S6K. This process promotes TH1 
and TH17 cell differentiation and induces IL-10 production by 
CD4+ T cells (70). These studies show the pleiotropic functions of 
SCFAs in immune responses and provide evidence for targeting 
FA sensing pathways to modulate T cell responses.
Intracellular FAs are also recognized by peroxisome prolif-
erator-activated receptors (PPARs). The PPAR family of nuclear 
receptors has three isoforms: PPARα, PPARδ, and PPARγ. After 
recognizing their ligands, PPARs associate with the retinoid X 
FigURe 3 | Fatty acid (FA) and cholesterol sensing in T cell immune responses. (A) FA metabolism and sensing serve multiple roles in T cell biology. 
Short-chain fatty acids (SCFAs) diffuse passively or are transported into cells by G-protein-coupled receptors. SCFAs can inhibit histone deacetylases and induce 
TH1 and TH17 cell differentiation and IL-10 production. De novo FA synthesis is required for TH17 generation. Intracellular FAs are recognized by peroxisome 
proliferator-activated receptors (PPARs). Expression of PPARγ is important for visceral adipose tissue Treg cell accumulation and function, while antagonizing PPARγ 
by chemical drug promotes TH17 development. (B) Cholesterol and cholesterol sulfates regulate T cell receptor (TCR) nanoclustering and signaling within the T cell. 
After stimulation of TCRs, T cells upregulate the cholesterol biosynthesis pathway through the SREBP/SCAP axis. This increase in cholesterol biosynthesis is 
important for acquiring T cell effector function. Additionally, intracellular sterols serve as ligands for intracellular receptors and transcription factors, such as liver X 
receptor (LXR) and RORγt to modulate TH17 development.
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receptor heterodimer, which binds PPAR-responsive elements to 
promote gene transcription (73). PPARγ is an important regula-
tor of effector T cell functions, as PPARγ-deficient CD4+ T cells 
cannot proliferate and survive in a lymphopenic environment 
and hence are less capable of inducing autoimmunity and graft-
versus-host disease in mice (74). Antagonizing PPARγ promotes 
TH17 cell differentiation and increases the severity of EAE 
(75, 76). Excessive TH17 cell differentiation might also be linked 
to the role of PPARγ in Treg cell differentiation. Indeed, PPARγ 
is essential for the maintenance and accumulation of Treg cells 
in adipose tissue (77). Thus, PPARγ serves as a key regulator of 
CD4+ T cell function and differentiation.
Cholesterol
To facilitate ligand recognition and initiate efficient signaling, 
several TCRs must oligomerize into nanoclusters (78). This pro-
cess is controlled by cholesterol and its derivatives. Cholesterol-
facilitated nanoclustering of TCRs enhances the avidity of 
the TCR toward its ligand (79). Conversely, cholesterol sulfate 
and cholesterol esters antagonize TCR function by displacing 
cholesterol and disrupting the formation of nanoclusters (80). 
Interestingly, cholesterol may serve temporal or spatial roles in 
TCR signaling. Cholesterol is an allosteric inhibitor of the TCRβ 
transmembrane domain and hence limits spontaneous TCR 
activation; however, the spontaneous unbinding of cholesterol 
in this region switches the conformation from inactive to active, 
allowing for the transmission of TCR signals (81). Therefore, 
cholesterol level in the plasma membrane of T cells is important 
for regulating TCR activity, which may contribute to T cell devel-
opment and functions under different conditions.
Intracellular concentrations of cholesterol play key roles in 
both development and effector functions of T cells. Inhibition 
of the esterification enzyme acetyl-coenzyme A acetyltrans-
ferases 1 increases cholesterol content in the plasma membrane 
of CD8+ T  cells, which augments TCR nanoclustering and 
subsequently increases effector CD8+ T  cell functions (82). 
Furthermore, deletion of ATP-binding cassette sub-family G 
member 1 (ABCG1), a protein promoting cholesterol efflux 
from cell, leads to an accumulation of intracellular cholesterol 
in Treg cells and increase in Treg cell frequency. Mechanistically, 
loss of ABCG1 and subsequent disruption in intracellular 
cholesterol distribution decreases mTOR activity and increases 
STAT5 signaling, thereby promoting Treg cell formation (83). 
These data demonstrate that intracellular cholesterol levels are 
essential for T cell function.
Cholesterol and its derivatives can also serve as intracellular 
ligands to influence T cell differentiation and function. Specifically, 
cholesterol derivatives control TH17 cell differentiation by 
modulating liver X receptor (LXR) and retinoic acid responsive-
related orphan receptor γt (RORγt) activity. LXR engagement 
antagonizes TH17 cell development by mediating the binding of 
sterol response element-binding protein (SREBP)1 to the Il17a 
locus and blocking the upregulation of aryl hydrocarbon receptor 
(AHR) necessary to induce Il17a transcription (84). Additionally, 
many cholesterol biosynthetic intermediates and derivatives are 
natural ligands for RORγt, the master transcription factor for 
TH17 cell development (85–87). These derivatives include oxys-
terol, desmosterol, and many cholesterol intermediates generated 
between lanosterol and zymosterol biosynthesis. Pharmaceutical 
or genetic disruption of these metabolites limits TH17 cell gen-
eration and ameliorates the severity of EAE (85–87). If and how 
cholesterol intermediates influence other effector CD4+ T  cell 
differentiation require further investigation.
FA and Cholesterol Biosynthesis
The ability to sense cholesterol and generate de novo choles-
terol is also critical for the activation and effector functions of 
T cells. Cholesterol synthesis is regulated within the cell by the 
transcription factor, SREBP2, and its chaperone SREBP cleav-
age activating protein (SCAP), which helps sense intracellular 
cholesterol levels (88). T cell activation induces the activation of 
SULT2B1, an oxysterol-metabolizing enzyme, which indirectly 
enhances SREBP2-dependent cholesterol synthesis by limiting 
oxysterols that activate LXR. Thus, SULT2B1 limits cholesterol 
export from the cell by blocking the LXR-dependent upregula-
tion of cholesterol-modifying enzymes and transporters (89). 
Intrinsic SCAP expression is required for T  cell proliferation 
and effector function (90). While SCAP-deficient T cells develop 
normally and are capable of undergoing homeostatic prolifera-
tion, they do not generate the requisite lipids for cell growth 
induced by TCR stimulation (90). Whether SCAP deficiency 
affects TCR nanonclustering is unknown, but early TCR signal-
ing is not impaired in the absence of SCAP despite these cells 
having reduced total cholesterol.
TCR stimulation-induced lipid biosynthesis is dependent 
on mTORC1 activation (90). Naïve CD4+ T  cells deficient in 
Raptor, an obligatory component of mTORC1, neither efficiently 
upregulate the expression of SREBP or other cholesterol-related 
genes nor appropriately grow and proliferate upon TCR and 
CD28 co-stimulation. These defects in cholesterol synthesis, 
along with compromised glycolysis and oxidative phosphoryla-
tion, are correlated with a reduced capacity to differentiate into 
effector CD4+ T  cells (91). Raptor-deficient Treg cells also have 
reduced cholesterol-related gene expression, which severely 
compromises Treg cell proliferation and suppressive function (92).
Of interest, the energy production and suppressive capacity 
of Treg cells are also linked to FA oxidation (FAO) (15), similar 
as memory CD8+ T cells (18). Memory CD8+ T cells fuel FAO 
via de novo lipid synthesis to support their homeostasis (18, 93). 
Additionally, de novo FA synthesis is crucial for the regulation 
of Treg and TH17 cell differentiation. Inhibition of acetyl-CoA 
carboxylase-1 (ACC1), a key enzyme for FA synthesis, promotes 
Treg cell and inhibits TH17 cell differentiation. Mechanistically, 
ACC1 deficiency limits FA synthesis and glycolysis needed for 
TH17 cell development (94). While the low level of exogenous 
FA intake may be enough to sustain Treg cells (94), future stud-
ies can explore if such interplay between FAO and de novo lipid 
synthesis and/or cholesterol catabolism contributes to Treg cell 
functions. Furthermore, identifying and characterizing the physi-
ological function of additional sterol-related metabolites in T cell 
responses may provide a novel approach to treat inflammatory 
diseases.
FigURe 4 | Oxygen sensing orchestrates T cell immune responses. In oxygen-replete environments, such as in the lung, prolyl-hydroxylase domain (PHD) 
proteins sense high levels of cellular oxygen. Activated PHD proteins establish immune tolerance in the lung by inducing hypoxia-inducible factor 1α (HIF1α) 
degradation to promote Treg cell and inhibit TH1 cell differentiation. Hypoxia induces HIF1α expression, which regulates the reciprocal generation of TH17 and Treg cells 
and antagonizes TH1 cell differentiation. HIF1α also temporally regulates Tr1 cell differentiation. HIF1α-dependent upregulation of S-2-hydroxyglutarate (S-2HG) 
enhances anti-tumor CD8+ T cell responses.
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OXYgeN SeNSiNg
Oxygen is required for aerobic respiration and mitochondrial 
energy generation, and the ability for cells to sense and respond 
to changing oxygen levels promotes their homeostasis. The cel-
lular mechanisms and signaling cascades of oxygen sensing are 
reviewed elsewhere (95, 96). Reactive oxygen species (ROS), such 
as peroxides, superoxide, hydroxyl radicals, and singlet oxygen, 
are byproducts of aerobic metabolism, and the accumulation of 
ROS causes cellular oxidative stress. ROS plays an important role 
in regulating T cell responses (97), which will not be discussed. 
Here, we focus on recent findings on the functions of the oxygen 
sensing components in T cells (Figure 4).
Prolyl-hydroxylase domain (PHD) proteins are expressed in 
T cells and function as intracellular oxygen sensors (98). In the 
lungs, high oxygen levels activate PHD proteins in T  cells to 
suppress TH1 responses and promote Treg cell induction (98). 
However, PHD protein-mediated pulmonary tolerance licenses 
tumor metastasis to the lungs, and inactivation of PHD proteins 
promotes anti-tumor T  cell responses (98). Mechanistically, 
activated PHD proteins induce the degradation of HIF1α 
through post-translational hydroxylation (99), which changes 
cellular metabolism to promote Treg cell generation and inhibit 
TH1 cell differentiation (98). Sensing of decreased oxygen levels 
(termed hypoxia) activates HIF1α, which induces glycolysis 
and provides T cells with the metabolic plasticity to adapt to 
environmental stress. T  cells are recruited to inflammatory 
sites that are often hypoxic (100), so how HIF1α controls T cell 
responses has been investigated. HIF1α is dispensable for 
T cell activation and early metabolic reprogramming in vitro 
(42), and HIF1α-deficient T cells also develop normally in vivo 
(101, 102). However, HIF1α-dependent glycolysis is crucial 
for promoting TH17 cell differentiation and inhibiting Treg cell 
generation (102). HIF1α also directly interacts with RORγt and 
Foxp3 to regulate the reciprocal differentiation of TH17 and Treg 
cells (101). HIF1α not only suppresses Treg cell generation (101, 
102), but augmented HIF1α activity also impairs Treg cell lineage 
stability and suppressive function in a VHL or Deltex1-deficient 
background (103, 104). Although increased HIF1α activity 
is associated with enhanced TH1 cell differentiation in PHD-
deficient T  cells (98), forced expression of a non-degradable 
mutant of HIF1α in TH1 cells inhibits IFN-γ expression, and 
TH1 cell differentiation is enhanced in HIF1α-deficient T cells 
after in vivo priming (105). Interestingly, HIF1α has differential 
effects on different stages of type 1 regulatory (Tr1) cell differ-
entiation. Tr1 cells are Foxp3 negative cells that produce IL-10 
to control inflammation (106). While HIF1α is required for 
the metabolic reprogramming during the early commitment of 
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Tr1 cells, its expression reduces at later time points to boost 
Tr1 cell differentiation by stabilizing AHR expression (107). 
Augmented HIF1α enhances the effector function of CD8 
T  cells (108). In the hypoxic tumor microenvironment, the 
VHL-HIF1α axis regulates CD8+ T cell responses by controlling 
the accumulation of S-2-hydroxyglutarate (S-2HG) in response 
to TCR stimulation (109). HIF1α promotes the expression of 
lactate dehydrogenase A that is the enzymatic source of S-2HG 
(109). S-2HG regulates the differentiation, in vivo proliferation 
and persistence of CD8+ T cells, and enhances their anti-tumor 
efficacy (109). Therefore, by sensing oxygen levels, HIF1α 
orchestrates T cell responses in given contexts.
RegULATiON OF eNeRgY AND ReDOX 
HOMeOSTASiS
Energy homeostasis is regulated by dynamic changes in cellular 
catabolic and anabolic pathways, which generate or consume 
ATP, respectively. Under conditions of energy and nutrient stress, 
T cells depend on sensors, such as AMPK, and catabolic pathways, 
such as autophagy, to replenish energy and cellular resources. 
Moreover, the redox balance mediated by NAD+/NADH is also 
implicated in T cell responses.
AMP-Activated Protein Kinase
Energy homeostasis is the basis of cell survival and function. 
AMPK is directly activated by an increased cellular AMP to ATP 
concentration during energy deprivation. AMPK functions as a 
fundamental regulator of T cell metabolism to inhibit anabolic 
pathways and to promote catabolic pathways to preserve cellular 
energy homeostasis (110). While the activation, regulation, and 
signaling of AMPK has been reviewed elsewhere (7, 111), here we 
will briefly discuss the functions of AMPK in T cells (Figure 5). 
AMPK is activated in glucose-deprived CD8+ T cells experienc-
ing energy stress, such as during infection and inflammation. 
AMPK is critical for both primary and memory CD8+ T  cell 
responses to infections (112, 113). In nutrient-limiting tumor 
microenvironment, CD8+ T cells also require AMPK activation 
for their survival to defend against tumors (114). The pro-survival 
functions of AMPK could also be linked to the induction of mac-
roautophagy, which is discussed in detail below (115).
In activated T  cells, AMPK is a master regulator of cellular 
metabolism. It preserves energy homeostasis by suppressing 
mRNA translation and promoting glutamine-fueled mitochon-
drial oxidization in response to glucose deprivation (112). The 
differentiation of TH1 and TH17 cells from naïve CD4+ T cells does 
not require AMPK activity, but their accumulation and their ability 
to induce inflammation in the colon are severely impaired in the 
absence of AMPK (112). However, AMPK activation is detrimen-
tal to T cell responses in certain contexts. In response to nutrient 
stress and DNA damage, active AMPK induces p38-dependent 
senescence in human CD4+ T cells, and silencing of AMPK restores 
telomerase activity and proliferation in senescent T  cells (116). 
Aberrant AMPK activation is linked to impaired TFH cell genera-
tion in T cells deficient in the ROQUIN RING domain (117). The 
AMPK agonist, 5-aminoimidazole-4-carboxamide ribonucleotide 
(AICAR), inhibits TH17 cell induction and promotes Treg cell 
generation in vitro (118), but these results should be interpreted 
cautiously due to the reported off-target effects of AICAR (119). 
Therefore, by sensing energy stress, AMPK plays a pivotal role in 
metabolic reprogramming to regulate T cell responses.
NAD+/NADH AND ReDOX BALANCe
The coenzyme β-nicotinamide adenine dinucleotide (NAD+) and 
its reduced form, NADH, are critical regulators of T cell biology. 
Early studies demonstrated that NAD+ induces apoptosis in T cells 
in a process called NAD+-induced cell death (NICD). When cells 
die as a result of tissue damage or inflammation, intracellular 
NAD+ is released into microenvironment, which then activates 
signaling to induce cell death. In T  cells, the accumulation of 
NAD+ increases ADP-ribosylation mediated by mono-ADP-
ribosyltransferase 2 (ART2) (120). The purinergic receptor P2X7 
is one substrate of ART2, and its ADP-ribosylation increases its 
sensitivity for activation by extracellular ATP, which initiates 
the cell death program (120). Consistent with this observation, 
elevated NAD+ levels generated during acute inflammation result 
in ART2-dependent decrease in peripheral CD4+ and CD8+ T cell 
numbers (121). Interestingly, peripheral T cells are more sensitive 
to NICD than thymocytes (120), suggesting a more dominant role 
for NAD+ in regulating peripheral T cell homeostasis. Compared 
to conventional T cells, Treg cells express higher levels of ART2 
and P2X7 and are more sensitive to NICD (122). In vivo NAD+ 
administration preferentially depletes Treg cells and enhances 
anti-tumor T  cell responses (122). Thus, localized changes in 
NAD+ levels likely influence the balance between conventional 
and Treg cell responses.
The flux of electrons via mitochondrial electron transport 
chain (ETC) regulates NAD+/NADH redox balance important 
for maintaining mitochondrial function and energy metabolism 
(123). Furthermore, perturbations in ETC alter NAD+/NADH 
levels and attenuate T  cell proliferation. Recently, mechanisms 
linking ETC dysfunction and impaired proliferation of Jurkat 
leukemic T  cells were uncovered. Disruption of ETC alters 
NAD+/NADH redox balance and limits mitochondrial aspartate 
synthesis, a process linked to purine and pyrimidine biosynthesis 
and protein synthesis (124). Pyruvate supplementation restores 
NAD+ levels and increases aspartate aminotransferase (GOT1)-
dependent aspartate synthesis (124). However, when GOT1 
(encodes for GOT1) is deleted from Jurkat cells, NAD+ levels 
and aspartate levels are further depleted, leading to increased 
Jurkat cell arrest following ETC inhibition (124). Thus, aspartate 
synthesis is limiting for proliferation when ETC is inhibited. The 
regulatory role of aspartate biosynthesis in primary T cell devel-
opment and function is unexplored; however, because aspartate 
synthesis is linked to purine nucleotide biosynthesis important 
for T cell proliferation (56), this pathway likely plays an important 
role in these cells.
Recent studies highlight the role of NAD+ in regulating 
CD4+ T cell differentiation. NAD+ regeneration through mito-
chondrial respiration is essential for proper lysosome function, 
which restrains excessive TH1 cell generation both in vivo and 
in  vitro (125). NAD+ treatment blocks the induction of EAE 
in mice by promoting the generation of immunosuppressive 
FigURe 5 | AMP-activated protein kinase (AMPK) and energy sensing dictate T cell immunity. AMPK is activated by the increased AMP to ATP ratio, which 
indicates energy deprivation. AMPK functions as a master regulator of cellular metabolism to preserve cellular energy homeostasis. AMPK activity is required for 
CD8+ T cell survival during infection and in tumor microenvironment. The accumulation of TH1 and TH17 cells in the colon is also dependent on AMPK activity. 
Aberrant AMPK activation is linked to impaired TFH cell generation and CD4+ T cell senescence.
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IFN-γ+IL-10+ CD4+ T  cells (126). Collectively, these stud-
ies highlight the potential for novel NAD+-based immune 
modulation.
Autophagy
Macroautophagy, hereafter referred to as autophagy, is an evolu-
tionarily conserved cellular process that breaks down endogenous 
cytosolic materials and organelles (127). Autophagy helps regu-
late energy consumption and cellular resources during cellular 
stress. Indeed, amino acid starvation and other energy-stressing 
conditions induce autophagy, which in part depends upon AMPK 
and mTORC1 signaling (128). How nutrient availability regulates 
autophagy in T  cells remains elusive. Earlier in  vitro studies 
showed evidence for increased autophagy in T cells after TCR and 
cytokine stimulation (129–131). However, in vivo, virus-specific 
CD8+ T cells downregulate autophagy during clonal expansion 
(132). In contrast, during the contraction phase, autophagy is 
upregulated in virus-specific CD8+ T  cells (132). Furthermore, 
upregulation of autophagy is critical for CD8+ T  cell memory 
formation, as acute deletion of Atg7 or Atg5 in peripheral CD8+ 
T cells impairs survival during the contraction phase, resulting in 
a decreased memory CD8+ T cell pool (132). Thus, the regulation 
of autophagy during the kinetics of T cell responses is dynamic. 
The contribution of cellular stress conditions, such as nutrient 
levels, growth factor withdrawal, energy, and oxidative stress, in 
regulating autophagy and effector T cell responses remains to be 
further elucidated.
Recent studies have shown that autophagy regulates CD4+ 
T  cell lineage differentiation and functionality. Treg cells have 
increased autophagosomes compared to conventional CD4+ 
T cells (33, 133, 134). Treg cell-specific deletion of genes required 
for autophagy (Atg7, Atg5, Atg16l1) reduces Treg cell survival, 
stability of Foxp3 expression and ability to control pro-inflam-
matory CD4+ T  cell responses (33, 133). Furthermore, loss of 
autophagy in Treg cells aberrantly elevates mTORC1 and c-Myc 
expression, which enhances glycolysis and limits Treg cell stability 
and function (33). This is in contrast to autophagy-dependent 
reactivation of mTORC1 signaling under conditions of sustained 
nutrient deprivation (135). Interestingly, the microenvironment 
may alter the role of autophagy in T  cells, as Atg16l1-deficient 
CD4+ T cells had elevated TH2 cell responses selectively within the 
intestinal environment (133). How autophagy regulates mTORC1 
signaling is not completely understood. In Treg cells, autophagy 
may selectively target PI(3)K-related signaling proteins for deg-
radation (33). In effector T cells, autophagy selectively degrades 
Bcl-10, affecting the signaling between TCR and NF-κB (136). 
Interestingly, the CARMA1/Bcl-10/MALT1 complex contributes 
to the upregulation of ASCT2 expression and glutamine uptake 
in TCR activated T cells, which controls mTORC1 activation (41). 
Thus, the role of autophagy in T cells is complex, as it not only 
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regulates cellular degradation in times of nutrient deprivation but 
also serves to modulate TCR signaling.
CONCLUDiNg ReMARKS
While it is clear that the interplay of nutrient sensing, signaling 
proteins, and cellular metabolism controls T  cell functional 
fitness, it remains an open question as to how T  cells sense 
dynamic nutrient cues in complex inflammatory contexts. 
Recent studies have begun to identify specific nutrients, 
nutrient sensors, and nutrient transporters that are crucial for 
proper T cell immune responses. However, the importance of 
additional sensors identified in other cellular systems remains 
to be explored in T cells. For example, SLC38A9 and Castor1 
are proteins associated with the lysosomes that directly bind 
intracellular arginine, leading to downstream regulation of 
mTORC1 signaling (52–54). Recent studies have also shown 
that ion sensing regulates T cell immunity (137, 138), but how 
ion and other nutrients cooperate to control T cell responses 
remains to be established. One major challenge in study-
ing nutrient and energy sensing is to identify key molecules 
involved in these processes. The development of cutting-edge, 
gene-targeting technologies, such as CRISPR, will likely allow 
us to identify additional molecules that specifically control 
selective aspects of T cell functions. Furthermore, the complex 
interplay between nutrient and cellular stress signals should 
also be explored in the context of cancer, autoimmunity, and 
infectious diseases to gain a better understanding of how 
T cell functional responses adapt to different physiological and 
pathological conditions. A detailed understanding of nutrient 
sensing in T cells has the potential to be translated into innova-
tive therapies for immune-mediated diseases and cancer.
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